Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Eslicarbazepine. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN107033079A details a high-purity Eslicarbazepine Acetate method. Achieve cost reduction and supply chain reliability with scalable pharmaceutical manufacturing.
Patent CN102465159B details a green microbial route for Eslicarbazepine. Enhance supply chain reliability and reduce manufacturing costs with this scalable biocatalytic technology.
Patent CN102465159B enables green microbial synthesis. Reduces cost and improves supply chain reliability for epilepsy drug intermediates significantly.
Patent CN115948357A reveals novel ketoreductase mutants for eslicarbazepine production, offering superior stereoselectivity and cost-effective biocatalytic manufacturing solutions.
Patent CN102250005A details a novel chiral catalytic hydrogenation route for Eslicarbazepine, offering superior atom economy and simplified purification for API manufacturing.
Novel asymmetric catalytic method for Eslicarbazepine production. Reduces operational cost and improves supply chain reliability for global pharmaceutical intermediates.
Patent CN102465159A reveals a green microbial route for Eslicarbazepine. Discover cost-effective, high-purity manufacturing solutions for API intermediates.
Patent CN110790708A details a novel iridium-catalyzed asymmetric hydrogenation route for Eslicarbazepine intermediates, offering high enantioselectivity and atom economy for pharmaceutical manufacturing.